本页面由Tiger Trade Technology Pte. Ltd.提供服务

诺和诺德

48.77
+0.59001.22%
盘后48.71-0.0600-0.12%17:52 EDT
成交量:1,079.64万
成交额:5.29亿
市值:2,164.93亿
市盈率:11.53
高:49.52
开:48.83
低:48.71
收:48.18
52周最高:71.80
52周最低:35.12
股本:44.39亿
流通股本:31.88亿
量比:1.38
换手率:0.34%
股息:1.72
股息率:3.53%
每股收益(TTM):4.23
每股收益(LYR):3.62
净资产收益率:71.40%
总资产收益率:19.25%
市净率:7.24
市盈率(LYR):13.47

数据加载中...

2026/06/22

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2026/06/22

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2026/06/22

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/10

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/02/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/06/27

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2025/06/27

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2025/05/30

关联方拟减持公告

Form 144 | Innate Pharma SA 10% 股东 Novo Nordisk A/S 拟减持921897股,总价约197万美元
2025/02/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/21

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/06/21

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/01/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/11/24

SEC问询函

Form CORRESP - Correspondence
2023/11/09

SEC问询函

Form CORRESP - Correspondence
2023/10/20

SEC问询函

Form CORRESP - Correspondence
2023/09/29

SEC问询函

Form CORRESP - Correspondence
2023/09/13

SEC问询函

Form CORRESP - Correspondence
2023/06/28

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2023/06/28

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2023/02/01

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]